Vaccine News and Research

Latest Vaccine News and Research

Gates discusses foundation's global health priorities in India during visit to country

During a visit to the Indian state of Bihar, Bill Gates, co-founder of the Bill & Melinda Gates Foundation, on Thursday discussed his foundation's work in India and global health priorities, ANI/Sify News reports.

28 Mar 2011

GCRI, Max Planck Florida Institute to host discussion on TB at German House New York

The German Center for Research and Innovation, in cooperation with the Max Planck Florida Institute, will host a discussion on the treatments and challenges of tuberculosis on Thursday, March 31, from 7:00 to 9:00 p.m. The event will take place at the German House New York.

28 Mar 2011

BMY receives FDA approval for YERVOY to treat metastatic melanoma

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration approved YERVOY 3 mg/kg for the treatment of patients with unresectable or metastatic melanoma.

28 Mar 2011

Scientists receive AACR Team Science Award for HPV research

The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human papillomavirus for more than 20 years.

28 Mar 2011

CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer

Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this second round of the commercialization award program.

25 Mar 2011

EU supports new collaborative research projects on tuberculosis

It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.

25 Mar 2011

Financial Times, other media outlets highlight key issues in Global TB fight

In recognition of World Tuberculosis Day on Thursday, the Financial Times published a series of stories on TB worldwide.

25 Mar 2011

Opinions: Using taxes to reduce poverty; fighting TB; meeting global food demands

To improve living standards and create jobs," African governments "need to provide their citizens with better health care, better education, more infrastructure. How to pay for this - in a way that is both fair and efficient - is a question that all governments face," Mark Plant, deputy director of the IMF's African Department, writes in a BusinessDay opinion piece where he describes how increased tax revenues in several African countries have led to "in-roads into poverty reduction."

25 Mar 2011

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

The Food and Drug Administration today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

25 Mar 2011

Diabetes management accepted for coverage by Chemical Abstracts

Future Medicine Ltd announces today that its new journal Diabetes Management (ISSN 1758-1907) which launched in January 2011 has been selected for coverage by Chemical Abstracts.

24 Mar 2011

WHO report urges countries to step up fight against drug-resistant TB

A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.

24 Mar 2011

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.

24 Mar 2011

U-M professors recommend certain steps to reach research equipoise

In 1998, a study linking the measles, mumps and rubella vaccine to autism in children appeared in a respected medical journal. For a decade, the study grabbed headlines worldwide.

23 Mar 2011

Biologists decipher molecular code regulating availability of brain channel linked to neuronal excitability

A key question in protein biochemistry is how proteins recognize "correct" interaction partners in a sea of cellular factors. Nowhere is that more critical to know than in the brain, where interactions governing channel protein activity can alter an organism's behavior.

23 Mar 2011

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

"The Obama administration and Congress should continue efforts to strengthen the safety of America's drug supply and, simultaneously, coordinate a global response to the problem of counterfeit drugs," Thomas Kubic, president & CEO of the Pharmaceutical Security Institute and a former deputy assistant director at the FBI, writes in a post on The Hill's "Congress Blog," where he describes the health risks associated with such drugs.

23 Mar 2011

Researchers launch free online Atlas of TB vaccination policies around the world

Tuberculosis continues to pose a major global health threat. Someone in the world is newly infected with TB bacteria every second. Every year, more than 9 million people develop active TB and it claims about 2 million lives.

22 Mar 2011

Researchers to develop house dust mite allergy vaccine that can cure asthma

Monash University researchers are working on a vaccine that could completely cure asthma brought on by house dust mite allergies.

22 Mar 2011

BMY's ipilimumab Phase III study against metastatic melanoma meets primary endpoint

Bristol-Myers Squibb Company today announced that a clinical trial -- known as study 024 -- of its investigational compound ipilimumab has met the primary endpoint of improving overall survival in previously-untreated patients with metastatic melanoma.

22 Mar 2011

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

NasVax announces the success of a Phase 2a clinical trial of a new oral immunotherapy for non-alcoholic steatohepatitis (NASH), an inflammatory disease associated with fatty liver disease and the metabolic syndrome.

21 Mar 2011

Medicago launches clinical development of seasonal flu vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that the first dose of vaccine has been administered thereby initiating the Company's phase I H1N1 influenza VLP vaccine candidate ("H1N1 vaccine") clinical trial in the United States. The primary safety and immunogenicity results for this trial are expected within three months.

21 Mar 2011

Vaccine News and Research

Latest Vaccine News and Research

Gates discusses foundation's global health priorities in India during visit to country

GCRI, Max Planck Florida Institute to host discussion on TB at German House New York

BMY receives FDA approval for YERVOY to treat metastatic melanoma

Scientists receive AACR Team Science Award for HPV research

CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer

EU supports new collaborative research projects on tuberculosis

Financial Times, other media outlets highlight key issues in Global TB fight

Opinions: Using taxes to reduce poverty; fighting TB; meeting global food demands

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

Diabetes management accepted for coverage by Chemical Abstracts

WHO report urges countries to step up fight against drug-resistant TB

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

U-M professors recommend certain steps to reach research equipoise

Biologists decipher molecular code regulating availability of brain channel linked to neuronal excitability

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

Researchers launch free online Atlas of TB vaccination policies around the world

Researchers to develop house dust mite allergy vaccine that can cure asthma

BMY's ipilimumab Phase III study against metastatic melanoma meets primary endpoint

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

Medicago launches clinical development of seasonal flu vaccine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Vaccine News and Research

Latest Vaccine News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in